A recent systematic review analyzed the role of vascular (e.g. VWF, homocysteine) and systemic (e.g. CRP, IL-6) inflammatory biomarkers in relation to cerebral small vessel disease (SVD) in a non-CKD population. This evidence concerns the gene IL6 and chronic kidney disease.